Anticoagulant recalled after failed test
The new recall includes multiple lots of dabigatran etexilate capsules, a DOAC that reduce's a heart patient's risk of stroke or blood clots.
The new recall includes multiple lots of dabigatran etexilate capsules, a DOAC that reduce's a heart patient's risk of stroke or blood clots.
What's Your Reaction?
